Zogenix (ZGNX) Tops Q3 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. MRVL
6. ABBV
7. CL
8. TFII
9. ORCL
10. PLTR

Go back to Zogenix (ZGNX) Tops Q3 EPS by 9c

Zogenix Provides Corporate Update and Reports Third Quarter 2015 Financial Results

November 9, 2015 4:01 PM EST

SAN DIEGO, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, provided a corporate update, and announced financial results for the third quarter ended September 30, 2015.

Corporate Update

Continued preparations for the Phase 3 program for ZX008, which is expected to begin in the fourth quarter of 2015 for the treatment of Dravet syndrome, a rare and debilitating form of epilepsy that begins in infancy. Key recent activities include: Submitted Investigational New Drug (IND) Application to the U.S.... More